CCI approves stakes of Temasek and Goldman Sachs in PharmEasy
CCI approved the subscription of PharmEasy's compulsory convertible preference shares (CCPS) by Goldman Sachs India, Temasek-owned MacRitchie Investments and EvolutionX, and CDPQ (Canadian pension fund). CCI also approved the additional shareholding of Prosus in API Holdings, PharmEasy's parent company.